http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2010029104-A3

Outgoing Links

Predicate Object
assignee http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_4f01b4900dad885fe6ac831204d6c2c6
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_33f3ed25c5aaf85ed57bcebddfb7c161
classificationCPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K45-06
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P31-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-665
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K38-12
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P31-04
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K38-12
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-665
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K45-06
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P31-04
filingDate 2009-09-09-04:00^^<http://www.w3.org/2001/XMLSchema#date>
inventor http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_7deecee59d6dc04a0b66328675874186
publicationDate 2010-06-17-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber WO-2010029104-A3
titleOfInvention Use of a pharmaceutical composition for the local treatment of infections, and medical product
abstract The invention relates to the use of a pharmaceutical composition for locally treating infections. According to the invention, the pharmaceutical composition contains at least two antibiotics as essentially the only pharmaceutically active substances, one of which is fosfomycin or a pharmaceutically acceptable salt thereof, while another one is selected from among the group consisting of daptomycin, polymyxins, aminoglycosides, glycopeptides, and pharmaceutically acceptable salts thereof. The invention further relates to a medical product composed of such a pharmaceutical composition and a carrier material.
priorityDate 2008-09-09-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isCitedBy http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-6468967-B1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/GB-1530017-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2005110022-A2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2007191280-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-0153330-A2
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226415516
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226415515
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID57011757
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID16134395

Total number of triples: 28.